{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:49:58Z","timestamp":1773938998654,"version":"3.50.1"},"reference-count":13,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"unspecified","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2026,2,24]]},"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:p>Calcium channel blockers are a common cause of poisoning and are associated with high mortality in affected patients. Treatment is complex. Although poorly researched, high-dose insulin euglycaemic therapy (HIET) appears to be an effective treatment. In this case report, we review a patient with a severe calcium channel blocker overdose who was successfully treated with HIET.<\/jats:p>","DOI":"10.1136\/bcr-2025-268547","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:30:23Z","timestamp":1773934223000},"page":"e268547","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["High-dose insulin euglycaemic therapy for a severe calcium channel blocker overdose"],"prefix":"10.1136","volume":"19","author":[{"given":"Massimo","family":"Catarinella","sequence":"first","affiliation":[{"name":"Cardiology, OLVG, Amsterdam, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Endeman","sequence":"additional","affiliation":[{"name":"Intensive Care Medicine, OLVG, Amsterdam, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"2026031908301497000_19.3.e268547.1","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1080\/15563650.2017.1388087","article-title":"2016 Annual Report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 34th Annual Report","volume":"55","author":"Gummin","year":"2017","journal-title":"Clin Toxicol (Phila)"},{"key":"2026031908301497000_19.3.e268547.2","unstructured":"McKeever RG , Patel P , Hamilton RJ . Calcium channel blockers. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2025."},{"key":"2026031908301497000_19.3.e268547.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-6757(03)00088-3"},{"key":"2026031908301497000_19.3.e268547.4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.27739","article-title":"Management of Acetaminophen Poisoning in the US and Canada: A Consensus Statement","volume":"6","author":"Dart","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026031908301497000_19.3.e268547.5","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000278916.04569.23"},{"key":"2026031908301497000_19.3.e268547.6","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2014.965827"},{"key":"2026031908301497000_19.3.e268547.7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/MAT.0000000000002307","article-title":"Predictors of Mortality in Adults With Calcium Channel Blocker Toxicity Receiving Extracorporeal Membrane Oxygenation Support: An Extracorporeal Life Support Organization Registry Analysis","volume":"71","author":"Subramanian","year":"2025","journal-title":"ASAIO J"},{"key":"2026031908301497000_19.3.e268547.8","first-page":"73","article-title":"High-dose insulin euglycemic therapy","volume":"61","author":"Hamzi\u0107","year":"2022","journal-title":"Acta Clin Croat"},{"key":"2026031908301497000_19.3.e268547.9","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4037\/ajcc2007.16.5.498","article-title":"Hyperinsulinemic euglycemia therapy for verapamil poisoning: a review","volume":"16","author":"Patel","year":"2007","journal-title":"Am J Crit Care"},{"key":"2026031908301497000_19.3.e268547.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105313442215"},{"key":"2026031908301497000_19.3.e268547.11","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-007-0768-y"},{"key":"2026031908301497000_19.3.e268547.12","article-title":"Management of calcium channel antagonist overdose with hyperinsulinemia-euglycemia therapy: case series and review of the literature","volume":"2012","author":"Shah","year":"2012","journal-title":"Case Rep Crit Care"},{"key":"2026031908301497000_19.3.e268547.13","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0022-3565(25)39488-7","article-title":"Insulin is a superior antidote for cardiovascular toxicity induced by verapamil in the anesthetized canine","volume":"267","author":"Kline","year":"1993","journal-title":"J Pharmacol Exp Ther"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2025-268547","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:30:25Z","timestamp":1773934225000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2025-268547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":13,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,19]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1136\/bcr-2025-268547"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2025-268547","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}